Angiosarcoma is a rare
malignant mesenchymal tumor with poor prognosis. We aimed to identify
malignancy-associated
miRNAs and their target genes, and explore biological functions of
miRNA and its target in
angiosarcoma. By
miRNA microarrays and reverse transcription polymerase chain reaction, we identified 1 up-regulated
miRNA (miR-222-3p) and 3 down-regulated
miRNAs (miR-497-5p, miR-378-3p and miR-483-5p) in human
angiosarcomas compared with human
capillary hemangiomas. The
intermediate-conductance calcium activated potassium channel KCa3.1 was one of the putative target genes of miR-497-5p, and marked up-regulation of KCa3.1 was detected in
angiosarcoma biopsy specimens by immunohistochemistry. The inverse correlation of miR-497-5p and KCa3.1 also was observed in the ISO-HAS
angiosarcoma cell line at the
mRNA and
protein levels. The direct targeting of KCa3.1 by miR-497-5p was evidenced by reduced
luciferase activity due to complementary binding of miR-497-5p to KCa3.1
mRNA 3' untranslated region. For the functional role of miR-497-5p/KCa3.1 pair, we showed that application of
TRAM-34, a specific KCa3.1 channel blocker, or transfection of ISO-HAS cells with KCa3.1
siRNA or miR-497-5p mimics inhibited cell proliferation, cell cycle progression, and invasion by down-regulating cell-cycle related
proteins including
cyclin D1, surviving and P53 and down-regulating matrix
metallopeptidase 9. In an in vivo
angiosarcoma xenograft model,
TRAM-34 or miR-497-5p mimics both inhibited
tumor growth. In conclusion, the
tumor suppressor miR-497-5p down-regulates KCa3.1 expression and contributes to the inhibition of
angiosarcoma malignancy development. The miR-497-5p or KCa3.1 might be potential new targets for
angiosarcoma treatment.